GOLDMAN SACHS GROUP INC

Holdings History for Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

Symbol: ATXS
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$9,343,917	713,821	+484,658	+211%	$13.09	Q4 2025
30 Sep 2025	0%	+0%	$1,668,307	229,163	+51,851	+29%	$7.28	Q3 2025
30 Jun 2025	0%	+0%	$950,392	177,312	+18,724	+12%	$5.36	Q2 2025
31 Mar 2025	0%	-0%	$846,860	158,588	-57,954		$5.34	Q1 2025
31 Dec 2024	0%	-0%	$1,935,885	216,542	-55,300	-20%	$8.94	Q4 2024
30 Sep 2024	0%	-0%	$2,992,980	271,842	-123,303	-31%	$11.01	Q3 2024
30 Jun 2024	0%	+0%	$3,595,820	395,145	+181,611	+85%	$9.10	Q2 2024
31 Mar 2024	0%	+0%	$3,005,491	213,534	+197,158	+1204%	$14.07	Q1 2024
31 Dec 2023	0%	-0%	$125,768	16,376	-12,154	-43%	$7.68	Q4 2023
30 Sep 2023	0%	+0%	$212,833	28,530	+2,897	+11%	$7.46	Q3 2023
30 Jun 2023	0%	-0%	$213,523	25,633	-46,524	-64%	$8.33	Q2 2023
31 Mar 2023	0%	+0%	$959,688	72,157	+72,157	NEW	$13.30	Q1 2023
31 Dec 2021		-0%	$0	0	-11,221	-100%	$12.58	Q4 2021
30 Sep 2021	0%	+0%	$99,000	11,221	+11,221	NEW	$8.82	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.